Canaccord’s Confident Take: Synergy Pharmaceuticals Could See Exciting Commercial Potential Boost Come 2018

S.A. Team-November 10, 2017, 1:32 PM EDT

Synergy Pharmaceuticals (NASDAQ:SGYP) stock may be getting some heat in the market today after releasing third quarter results yesterday, yet one bullish voice rises above the dip.

Story Continues

Synergy Pharmaceuticals

Wall Street Pours Cold Water on Netflix (NFLX), Analysts Weigh In

5 Takeaways From Micron (MU)-Intel (INTC) 3D XPoint Split: Goldman Sachs

Applied Optoelectronics (AAOI) Will Be Most Vulnerable to the $200B Chinese Tariff Proposal; Analyst Reiterates a Neutral Rating on the Stock

Helios and Matheson (HMNY) Investors Are Likely to See a Bankruptcy Than to Recoup Gains, Says Top-Ranked Blogger

SenesTech (SNES) Stock Fires on All Cylinders

Here’s Why You Shouldn’t Get Too Excited About AcelRx Pharmaceuticals (ACRX) Stock

Hedge Fund Whiz Anand Parekh Drops the Ax on Micron (MU)

Quant Wizard Cliff Asness Takes Some Profits off the Table from Micron (MU), Charges Up Advanced Micro Devices (AMD)

3 Big Name Stocks Hedge Fund Billionaires Are Buying: Micron (MU), Qualcomm (QCOM), Apple (AAPL)

Alexa Supercharged with Vanywhere and Crypto-Currency Can Be a Game Changer

Is Ripple (XRP) Ready for a Breakout?

Bitcoin Can Theoretically Bottom Around March 2019 and Climb Back Around March 2021, Says Top Analyst

Facebook (FB) Set To Crush An ‘Unbelievable’ Earnings Season

StockMetrix: Should You Buy Apple (AAPL) Stock or Microsoft (MSFT)?

Tesla (TSLA): Why Musk Reveal as GOP Donor Could Hit the Stock

Canaccord’s Confident Take: Synergy Pharmaceuticals Could See Exciting Commercial Potential Boost Come 2018